Heart Failure
Heart failure, also known as congestive heart failure, is a progressive condition where the heart cannot pump enough blood to oxygenate the body's tissues, typically resulting in symptoms like shortness of breath, fatigue, and leg swelling. It is a leading cause of hospitalization for patients over 65 in the U.S. and is often caused by other heart conditions that alter the heart's structure and function.
Health Outcomes
- Altered Catecholamine Level
- Association with Sarcopenia
- Attenuated Blood Pressure (Inactivated Cells Only)
- Changed Bicarbonate Level
- Changed Heart Rate
- Changed Walking Cadence
- Decreased Oxygen Saturation
- Decreased Oxygenated Hemoglobin Level
- Developed Endocarditis
- Enhanced Antioxidant Response
- Enhanced Cell Viability Under Oxidative Stress
- Enhanced Folate Synthesis
- Extended Cardiac Transplant Survival
- Extended Lifespan in Caenorhabditis elegans
- Identified ACE-Inhibitory Peptides
- Improved 6-Meter Walk Performance
- Improved 6-minute Walking Distance
- Improved Aerobic Capacity
- Improved Aerobic Endurance Performance
- Improved Aerobic Power
- Improved Aging-Related Changes
- Improved Anaerobic Power
- Improved Antihypertensive Activity
- Improved Antioxidant Levels
- Improved Antioxidative Capacity
- Improved Antioxidative Response
- Improved Arginine Metabolism
- Improved Blood Pressure
- Improved Cardiac Baroreflex Sensitivity
- Improved Cardiac Function
- Improved Cardiac Muscle Contractile Performance
- Improved Cardiac Muscle Structural Integrity
- Improved Cardioprotective Activity
- Improved Cardiovascular Disease Outcomes
- Improved Cardiovascular Function
- Improved Cardiovascular Health
- Improved Clinical Outcome
- Improved Clinical Outcomes
- Improved Clinical Success
- Improved Constant Work Rate Exercise Time
- Improved Cytoprotection During Oxidative Stress
- Improved Daily Activity Participation
- Improved Diastolic Function
- Improved Disease Management
- Improved Distance Traveled
- Improved Endothelial Reactivity
- Improved Endothelium-Dependent Vasodilation
- Improved Endothelium-Dependent Vasodilation in Resistance Arteries
- Improved Endothelium-Independent Microvascular Vasodilation
- Improved Endurance
- Improved Endurance Performance
- Improved Estimated VO2max
- Improved Event-Free Survival
- Improved Exercise Function
- Improved Exercise Performance
- Improved Exercise Stress Test Grade
- Improved Fatigue
- Improved Fatigue Symptoms
- Improved Fatigue Threshold
- Improved Fatigue Tolerance
- Improved Flow-Mediated Dilation
- Improved Flow-Mediated Vasodilation
- Improved Function Score
- Improved Functional Capacity
- Improved Functional Outcome
- Improved Functional Properties of Food
- Improved General Activity
- Improved Global Clinical Status
- Improved Global Quality of Life
- Improved Health Condition
- Improved Health Outcomes
- Improved Health Status
- Improved Heart Rate Recovery
- Improved Heart Rate Variability
- Improved Homeostasis
- Improved Human Health
- Improved Inotropic Function
- Improved Intermittent Exercise Performance
- Improved Lactate Threshold
- Improved Left Ventricular Ejection Fraction
- Improved Left Ventricular Global Longitudinal Strain
- Improved Limited Distance Test Performance
- Improved Lower Body Endurance
- Improved Lower Limb Peak Power
- Improved Maximal Exercise Capacity
- Improved Maximal Oxygen Capacity
- Improved Maximal Oxygen Uptake
- Improved Maximal Power
- Improved Maximal Walking Performance
- Improved Mean Arterial Pressure
- Improved Medication Adherence
- Improved Myocardial Strain
- Improved Myocardial Strain Rate
- Improved Overall Patient Outcomes
- Improved Oxidative Metabolism Regulation
- Improved Patient Satisfaction
- Improved Peak Anaerobic Power
- Improved Physical Domain Score
- Improved Physical Health-Related Quality of Life
- Improved Physical Performance
- Improved Physical Quality of Life
- Improved Physical Role Limitation
- Improved Physiological Parameters
- Improved Post-Myocardial Infarction Outcome
- Improved Quality of Life
- Improved Reactive Hyperemia Index
- Improved Right Ventricular Function
- Improved Run Time
- Improved Serum Biomarkers
- Improved Strength Endurance
- Improved Stress-Strain Index
- Improved Survival Rate Against Influenza Virus
- Improved Survival Rate Under Nitrite Stress
- Improved Survival at 24 Months
- Improved Symptom Control
- Improved Symptoms of Chronic Condition
- Improved Systolic Function
- Improved TBARS Levels
- Improved Time to Exhaustion
- Improved VO2max
- Improved Vagal Reactivation
- Improved Vasodilation
- Improved Walking Distance
- Improved Work Capacity
- Incidence of Death
- Increased ACE Inhibitor Activity
- Increased Antihypertensive Peptide Production
- Increased Antioxidant Levels
- Increased Blood Lactate Level
- Increased Days Alive and Out of Hospital
- Increased Deoxygenated Hemoglobin Level
- Increased Endurance Swimming Time
- Increased Exercise Capacity
- Increased Hospital Admissions
- Increased Hyperkalemia
- Increased Invasive Interventions Requirement
- Increased Lactate Level
- Increased Lactate Levels
- Increased Length
- Increased Maximal Incremental Cycling Capacity
- Increased Mortality
- Increased Mortality Rate
- Increased Nitrate Level
- Increased Occurrence of Serious Adverse Events
- Increased Organ Weights
- Increased Oxidative Stress Tolerance
- Increased Oxygen Uptake at Ventilatory Threshold
- Increased Plasma Haptoglobin Levels
- Increased Power Output at Ventilatory Threshold
- Increased Pro-inflammatory Cytokine TNFα Levels
- Increased Production of ACE-Inhibitory Peptides
- Increased Production of Bioactive Peptides with Angiotensin Converting Enzyme Inhibitory Activity
- Increased SalA-like Inhibitory Activity
- Increased Systolic Blood Pressure
- Increased Time to Exhaustion
- Increased Time to Ventilatory Threshold
- Increased Type 1 Collagen Synthesis
- Maintained Physical Performance
- Mitigated Adverse Physiological Processes
- Mitigated Cardiac Injury from Myocardial Infarction
- Neutralized Reactive Oxygen Species
- No Change in Major Cardiovascular Event
- No Difference in Adverse Events
- Normalized Serum IL-1β Levels
- Preserved Cardiac Function
- Prevented Sepsis
- Prolonged Cardiac Allograft Survival
- Reduced ACE Activity
- Reduced Acute Kidney Injury
- Reduced Adipose Tissue Wasting
- Reduced Adverse Physiometabolic Effects
- Reduced Angiotensin I-Converting Enzyme Activity
- Reduced Apelin Gene Expression
- Reduced Apolipoprotein B-100 to Apolipoprotein A-1 Ratio
- Reduced Appetite Changes
- Reduced Arginine Level
- Reduced Arterial Stiffness
- Reduced Bicarbonate Level
- Reduced Blood Pressure
- Reduced Cardiac Arrest Risk
- Reduced Cardiac Function
- Reduced Cardiac Hypertrophy
- Reduced Cardiac Injury
- Reduced Cardiac Output
- Reduced Cardiovascular Disease Mortality
- Reduced Cardiovascular Dysfunction
- Reduced Cardiovascular Event
- Reduced Cardiovascular Mortality
- Reduced Cause-Specific Mortality
- Reduced Central Blood Pressure
- Reduced Chloride Level
- Reduced Community Healthcare Costs
- Reduced Composite Score
- Reduced Contrast-Induced Acute Kidney Injury
- Reduced Coxsackievirus B3 Activity
- Reduced Coxsackievirus B3 Viral Load
- Reduced Cumulative Morbidity Rates
- Reduced Cumulative Mortality
- Reduced Dephosphorylated-Uncarboxylated Matrix Gla Protein Level
- Reduced Disability
- Reduced Drug Concentration
- Reduced Edema
- Reduced Emergency Care Unit Stay Duration
- Reduced Exertional Dyspnea
- Reduced Exhaustion During Stress Test
- Reduced Fat-Free Mass
- Reduced Fatigue Severity
- Reduced Free Triiodothyronine
- Reduced Functional Iron Deficiency
- Reduced HIF-1α Level
- Reduced Healthcare Costs
- Reduced Heart Rate Variability
- Reduced Heat Stress
- Reduced Homocysteine Level
- Reduced Hospital Length of Stay
- Reduced Hospital Mortality Rate
- Reduced Hospital Readmission Risk
- Reduced Hospital Stay
- Reduced Hospitalization Duration
- Reduced Hospitalization Rate
- Reduced Hypertension
- Reduced ICAM-1 Level
- Reduced In-hospital Mortality
- Reduced Incidence of Cardiovascular Disease
- Reduced Incidence of Influenza
- Reduced Inotropic Support Requirement
- Reduced Interleukin-15 Levels
- Reduced Iron-Corrected T1
- Reduced Lactate Levels
- Reduced Lean Mass
- Reduced Left Ventricular End-Diastolic Volume
- Reduced Length of Hospitalization
- Reduced Length of Intensive Care Unit Stay
- Reduced Length of Stay
- Reduced Lifespan
- Reduced Mean Arterial Blood Pressure
- Reduced Mean Arterial Pressure
- Reduced Mechanical Ventilation Duration
- Reduced Morbidity
- Reduced Mortality
- Reduced Mortality Rate
- Reduced Mortality Rate Before Discharge
- Reduced Mortality Rate under Stress
- Reduced Mortality Risk
- Reduced Muscular Endurance
- Reduced Myeloperoxidase (MPO) Concentration
- Reduced Myeloperoxidase Levels
- Reduced Myocardial Injury Cytokines
- Reduced NSAID Consumption
- Reduced Need for Continuous Renal Replacement Therapy
- Reduced Nitric Oxide Level
- Reduced Nocturia
- Reduced Non-Infectious Complication Morbidity
- Reduced Non-Programmed Medical Visits
- Reduced Omission Errors
- Reduced Organ Failure Severity
- Reduced Overall Mortality Rate
- Reduced Oxygen Cost of Exercise
- Reduced Physical Activity
- Reduced Physiological Impairments
- Reduced Power
- Reduced Protein Oxidation
- Reduced Pulse Pressure
- Reduced Quadriceps Muscle Cross-Sectional Area
- Reduced Renal Sympathetic Activity
- Reduced Respiratory Exchange Ratio
- Reduced Saturated Fatty Acids in Breast Meat
- Reduced Serious Adverse Events
- Reduced Short-term Mortality
- Reduced Stroke Volume
- Reduced Survival Rate
- Reduced Swimming Time
- Reduced Sympathetic Hyperactivity
- Reduced TMAO Level
- Reduced Taste Disturbance Incidence
- Reduced Total Triiodothyronine
- Reduced Treatment Costs
- Reduced Triiodothyronine Level
- Reduced Trimethylamine N-oxide Levels
- Reduced Troponin I Level
- Reduced Trypanosoma cruzi Parasitaemia
- Reduced Walking Time
- Regulated Blood Pressure
- Regulated Oxidative Stress
- Slower Weight Gain
- Stabilized Disease Progression
- Unchanged Survival Rate